Today: 2 July 2026
Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen
7 February 2026
1 min read

Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen

New York, Feb 7, 2026, 05:50 EST — Market closed.

Exxon Mobil closed out Friday’s session at $149.05, up 2.03%, hitting a new 52-week peak as energy names climbed alongside a wider U.S. equity upswing heading into the weekend.

Next week’s outlook? Messier. Oil’s been jerking around on the latest U.S.-Iran headlines, and that volatility feeds right into the big integrateds—Exxon among them. Brent closed out Friday at $68.05 a barrel. WTI, the U.S. benchmark, was at $63.55. “We keep going back and forth on this Iran situation,” said John Kilduff, partner at Again Capital. Reuters

Crude took a sharp dive just a day ago, with traders betting that negotiations might actually curb supply worries. “There is still scepticism that any reasonable deal can be made with Iran,” wrote Phil Flynn, senior analyst at Price Futures Group, in a comment to Reuters. Reuters

The U.S. State Department on Friday slapped sanctions on 15 companies and 14 vessels connected to Iranian oil and petrochemical trading, adding fresh pressure to the sector.

Iran’s foreign minister described the Oman-brokered discussions as a “good start” and indicated talks are set to go on. U.S. President Donald Trump, speaking to reporters, said his team plans another meeting with Iran early next week. Reuters

Exxon jumped on Friday as the broader market rallied, with the S&P 500 climbing 1.97% and the Dow Jones Industrial Average advancing 2.47%. Chevron ticked up 0.91%, while ConocoPhillips added 2.51% during the session—traders went back to cyclicals.

Refiners caught a slight break. The United Steelworkers signed off on a national deal, narrowly sidestepping a strike that threatened about 30,000 employees across 26 refinery and petrochemical operators, according to Reuters.

On the corporate front, Exxon shares are still basking in the momentum from its recent earnings. The oil giant surpassed analysts’ estimates in its fourth-quarter report dated Jan. 30, posting adjusted earnings of $1.71 a share—above the $1.68 Wall Street was looking for. Stronger output from both the Permian Basin and Guyana drove the beat, LSEG figures show, as reported by Reuters.

Mark Feb. 20 for Exxon watchers. The company told the SEC in a Jan. 30 filing it’s set to release a refreshed “Company Overview and Investment Case” presentation that day. Exxon Mobil Corporation

The risk is clear enough. Should the Iran premium evaporate and crude prices tumble, Exxon could drop just as quickly—recent sessions have already highlighted how abruptly sentiment can reverse in oil. Next up: traders will be eyeing the latest U.S.-Iran diplomatic signals when markets open Monday, tracking weekly U.S. crude inventory numbers midweek, and waiting for Exxon’s update on Feb. 20, looking for any fresh hints about its path through 2026.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Personalis (PSNL) Jumps, Now Seen as 27% Overvalued After Rally
    July 2, 2026, 1:12 AM EDT. Personalis Inc (PSNL) soared 83.74% in the past year as new biopharma partnerships and better operations drove more clinical testing. Revenue hit $64.5 million, but net loss was $95.6 million, so profitability concerns linger. The company trades at a roughly $1.4 billion market cap after shares climbed 22.5% in the last 30 days. Analysts note the stock looks about 27% overvalued versus a $10.86 fair value, and say it needs faster revenue growth and better margins to support current prices. They flag reimbursement risk and possible equity raises as headwinds. Investors weighing gains against risk in a fast-changing healthcare AI market.
Confluent stock edges higher as IBM deal vote nears after fresh merger filing
Previous Story

Confluent stock edges higher as IBM deal vote nears after fresh merger filing

Wells Fargo & Company stock drops 2% as CFO talks loan growth — what traders watch next
Next Story

Wells Fargo & Company stock drops 2% as CFO talks loan growth — what traders watch next

Go toTop